Reference no: EM13934199

1) Are the reasons for developing the guidelines clearly stated?  Yes No
Comments: What are the reasons?

2. Is there a satisfactory description of the patients to whom the guidelines are meant to apply? Yes No
Comments: Who are they?

3. Do the guidelines describe the condition to be detected, treated, or prevented in unambiguous terms? Yes No
Comments: If so, how is it described?

4. Do the guidelines list the patient outcomes that are considered? Yes No
Comments: If so, what are all of them?

5. Is there an adequate description of the health benefits that are likely to be gained from the recommended management? Yes No
Comments: What are the benefits?

6. Was a cost analysis done? Yes No
Comments: If so, what were the results?

7. Does the guideline document suggest possible methods for dissemination and implementation? Yes No
Comments: Is so, what are they?

8. Does the guideline document specify criteria for monitoring compliance? Yes No
Comments:

9. Does the guideline document identify key elements which need to be considered by local guideline groups? Yes No
Comments: What are these key elements?

10. What are the recommendations relevant to the PICO question? ( This is the PICO question: For adults over 50 years, does the use of fish oil supplements and/or omega-3 fatty acids reduce the future risk of cardiovascular disease compared with adults over 50 years who do not take these supplements.:

11. What is the level/type of evidence - I, II, III, IV, or V) for this source?